marketing wars over the new sleeping pills
You'll see marketing wars over the new sleeping pills... Lunesta, Rozerem, Ambien CR, and then indiplon next year.
Lunesta (eszopiclone) is making a big splash now to get a head start. It's the first one not limited to short-term use... but some patients complain about a bitter aftertaste.
Rozerem (ro-ZER-um) will be out this month. It's the first in a new class...melatonin receptor agonists.